Ellevest Inc’s Rallybio RLYB Stock Holding History

Ellevest Inc’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	–	–	1944
2022 Q3	$0	Hold	1	–	–	﹤0.01%	1817
2022 Q2	$0	Buy	+1	New	+$75	﹤0.01%	1640

Other funds holding RLYB

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ellevest Inc's RLYB Position: Q4 2022 in Review

Ellevest Inc sold out of Rallybio (RLYB) in Q4 2022, closing a stake of 1 share.

Ellevest Inc first reported a position in RLYB in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 57 funds tracked by Wall St. Rank hold RLYB as of Q4 2022.

Ellevest Inc reported no remaining Rallybio position as of Q4 2022 after selling out during the quarter.
Ellevest Inc sold 1 Rallybio share in Q4 2022.
Ellevest Inc first reported a position in Rallybio in Q2 2022 and held it in 2 quarters.
Ellevest Inc's Rallybio position peaked at $0 in Q3 2022.
57 funds tracked by Wall St. Rank held Rallybio as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.